Literature DB >> 8818396

Testosterone and progesterone metabolism in the central nervous system: cellular localization and mechanism of control of the enzymes involved.

L Martini1, F Celotti, R C Melcangi.   

Abstract

This paper summarizes the most recent data obtained in the authors' laboratory on the metabolism of testosterone and progesterone in neurons and in the glia. 1. The activities of 5 alpha-reductase (the enzyme that converts testosterone into dihydrotestosterone; DHT) and of 3 alpha-hydroxy steroid dehydrogenase (the enzyme that converts DHT into 5 alpha-androstane-3 alpha, 17 beta-diol; 3 alpha-diol) were first evaluated in primary cultures of neurons, oligodendrocytes, and type-1 and type-2 astrocytes, obtained from the fetal or neonatal rat brain. The formation of DHT and 3 alpha-diol was evaluated incubating the different cultures with labeled testosterone or labeled DHT as substrates. The results obtained indicate that the formation of DHT takes place preferentially in neurons; however, also type-2 astrocytes and oligodendrocytes possess considerable 5 alpha-reductase activity. A completely different localization was observed for 3 alpha-hydroxysteroid dehydrogenase; the formation of 3 alpha-diol appears to be prevalently, if not exclusively, present in type-1 astrocytes; 3 alpha-diol is formed in very low yields by neurons, type-2 astrocytes, and oligodendrocytes. Moreover, the results indicate that, in type 1 astrocytes, both 5 alpha-reductase and 3 alpha-HSD are stimulated by coculture with neurons and by the addition of neuron-conditioned medium, suggesting that secretory products released by neurons might intervene in the control of glial cell function. 2. Subsequently it was shown that, similarly to what happens when testosterone is used as the substrate, 5 alpha-reductase, which metabolizes progesterone into 5 alpha-pregnane-3,20-dione, (DHP), shows a significantly higher activity in neurons than in glial cells; however, also type-1 and type-2 astrocytes as well as oligodendrocytes possess some ability to 5 alpha-reduce progesterone. On the contrary, 3 alpha-hydroxysteroid dehydrogenase, the enzyme which converts DHP into 5 alpha-pregnane-3 alpha-ol-20-one (THP), appears to be present mainly in type-1 astrocytes; much lower levels of this enzyme are present in neurons and in type-2 astrocytes. At variance with the previous results obtained using androgens as precursors, oligodendrocytes show considerable 3 alpha-hydroxysteroid dehydrogenase activity, even if this is statistically lowe than that present in type-1 astrocytes. The existence of isoenzymatic forms of the enzymes involved in androgen and progesterone metabolism is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818396     DOI: 10.1007/bf02088095

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  55 in total

1.  Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells.

Authors:  I Jung-Testas; M Renoir; H Bugnard; G L Greene; E E Baulieu
Journal:  J Steroid Biochem Mol Biol       Date:  1992-03       Impact factor: 4.292

Review 2.  Estrogen effects on the synaptology and neural membranes of the rat hypothalamic arcuate nucleus.

Authors:  F Naftolin; L M Garcia-Segura; D Keefe; C Leranth; N J Maclusky; J R Brawer
Journal:  Biol Reprod       Date:  1990-01       Impact factor: 4.285

Review 3.  Co-existence between receptors, carriers, and second messengers on astrocytes grown in primary cultures.

Authors:  E Hansson
Journal:  Neurochem Res       Date:  1989-09       Impact factor: 3.996

4.  In vitro neurite extension by granule neurons is dependent upon astroglial-derived fibroblast growth factor.

Authors:  M E Hatten; M Lynch; R E Rydel; J Sanchez; J Joseph-Silverstein; D Moscatelli; D B Rifkin
Journal:  Dev Biol       Date:  1988-02       Impact factor: 3.582

5.  Interaction of oestrogen and of physiological progesterone metabolites in the control of gonadotropin secretion.

Authors:  M Zanisi; L Martini
Journal:  J Steroid Biochem       Date:  1979-07       Impact factor: 4.292

6.  Genetic evidence for androgen-dependent and independent control of aromatase activity in the rat brain.

Authors:  C E Roselli; R L Salisbury; J A Resko
Journal:  Endocrinology       Date:  1987-12       Impact factor: 4.736

7.  Estrogen-induced synaptic remodelling in adult rat brain is accompanied by the reorganization of neuronal membranes.

Authors:  G Olmos; P Aguilera; P Tranque; F Naftolin; L M Garcia-Segura
Journal:  Brain Res       Date:  1987-11-03       Impact factor: 3.252

8.  Neuronal activity up-regulates astroglial gene expression.

Authors:  O Steward; E R Torre; R Tomasulo; E Lothman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

9.  Effect of 1,4,6-androstatriene-3,17-dione (ATD), 4-hydroxy-4-androstene-3,17-dione (4-OH-A) and 4-acetoxy-4-androstene-3,17-dione (4-Ac-A) on the 5 alpha-reduction of androgens in the rat prostate.

Authors:  M Motta; S Zoppi; A M Brodie; L Martini
Journal:  J Steroid Biochem       Date:  1986-10       Impact factor: 4.292

10.  Studies on the possible existence of two 5 alpha-reductases in the rat prostate.

Authors:  L Martini; S Zoppi; M Motta
Journal:  J Steroid Biochem       Date:  1986-01       Impact factor: 4.292

View more
  11 in total

Review 1.  Neurogenic pain and steroid synthesis in the spinal cord.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Domitille Boudard; Véronique Schaeffer; Aurélie Béglé; Simona Saredi; Laurence Meyer; Ayikoe G Mensah-Nyagan
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.

Authors:  Roberto Frau; Giuliano Pillolla; Valentina Bini; Simone Tambaro; Paola Devoto; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2012-08-09       Impact factor: 4.905

Review 3.  Gonadal steroids and neuronal function.

Authors:  R Alonso; I López-Coviella
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

4.  Neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol.

Authors:  M J VanDoren; D B Matthews; G C Janis; A C Grobin; L L Devaud; A L Morrow
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

Review 5.  Hormones and the neuromuscular control of courtship in the golden-collared manakin (Manacus vitellinus).

Authors:  Barney A Schlinger; Julia Barske; Lainy Day; Leonida Fusani; Matthew J Fuxjager
Journal:  Front Neuroendocrinol       Date:  2013-04-25       Impact factor: 8.606

6.  Maternally derived hormones, neurosteroids and the development of behaviour.

Authors:  James C Mouton; Renée A Duckworth
Journal:  Proc Biol Sci       Date:  2021-01-27       Impact factor: 5.349

7.  Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors.

Authors:  Laura J Mosher; Sean C Godar; Marc Morissette; Kenneth M McFarlin; Simona Scheggi; Carla Gambarana; Stephen C Fowler; Thérèse Di Paolo; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2018-02-16       Impact factor: 4.905

8.  Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation.

Authors:  Roberto Frau; Valentina Bini; Romina Pes; Giuliano Pillolla; Pierluigi Saba; Paola Devoto; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2013-09-21       Impact factor: 4.905

9.  Ovarian steroids enhance object recognition in naturally cycling and ovariectomized, hormone-primed rats.

Authors:  Alicia A Walf; Madeline E Rhodes; Cheryl A Frye
Journal:  Neurobiol Learn Mem       Date:  2006-03-10       Impact factor: 2.877

10.  Expression of 5α- and 5β-reductase in spinal cord and muscle of birds with different courtship repertoires.

Authors:  Matthew J Fuxjager; Eric R Schuppe; John Hoang; Jennifer Chew; Mital Shah; Barney A Schlinger
Journal:  Front Zool       Date:  2016-06-10       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.